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Abstract
Background: Schistosoma mansoni is the major causative agent of schistosomiasis. The parasite takes advantage of host
signals to complete its development in the human body. Tumor necrosis factor-alpha (TNF-a) is a human cytokine involved
in skin inflammatory responses, and although its effect on the adult parasite’s metabolism and egg-laying process has been
previously described, a comprehensive assessment of the TNF-a pathway and its downstream molecular effects is lacking.
Methodology/Principal Findings: In the present work we describe a possible TNF-a receptor (TNFR) homolog gene in S.
mansoni (SmTNFR). SmTNFR encodes a complete receptor sequence composed of 599 amino acids, and contains four
cysteine-rich domains as described for TNFR members. Real-time RT-PCR experiments revealed that SmTNFR highest
expression level is in cercariae, 3.5 (60.7) times higher than in adult worms. Downstream members of the known human
TNF-a pathway were identified by an in silico analysis, revealing a possible TNF-a signaling pathway in the parasite. In order
to simulate parasite’s exposure to human cytokine during penetration of the skin, schistosomula were exposed to human
TNF-a just 3 h after cercariae-to-schistosomula in vitro transformation, and large-scale gene expression measurements were
performed with microarrays. A total of 548 genes with significantly altered expression were detected, when compared to
control parasites. In addition, treatment of adult worms with TNF-a caused a significantly altered expression of 1857 genes.
Interestingly, the set of genes altered in adults is different from that of schistosomula, with 58 genes in common,
representing 3% of altered genes in adults and 11% in 3 h-old early schistosomula.
Conclusions/Significance: We describe the possible molecular elements and targets involved in human TNF-a effect on S.
mansoni, highlighting the mechanism by which recently transformed schistosomula may sense and respond to this host
mediator at the site of cercarial penetration into the skin.
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Introduction
Schistosomiasis is a public health problem in many developing
countries, and Schistosoma mansoni is one of the most widespread
species of the causative trematode parasite, affecting 200 million
people in the world. Parasite eggs laid in the hepatic portal
vasculature are the principal cause of morbidity, and the resulting
pathology may prove fatal [1].
The complex parasite life cycle in the vertebrate host begins
when cercariae penetrate the human host skin, transforms into
schistosomula and begin their life as endoparasites. To continue
their development schistosomula take advantage of signals from
the host; co-evolution has allowed the schistosome parasite to sense
and respond to host mediators [2]. One of the important responses
of human host at the site of cercariae penetration in the skin is
TNF-a (Tumor necrosis factor alpha) cytokine production in the
early steps of the inflammatory process, along with the synthesis of
other cytokines such as IL-1, IL-8, TGF-b, IFN-c [3,4].
Human cytokines such as IL-7 and TGF-b have been described
as host signals that interfere with the metabolism, gene expression
and development of schistosomes [2,5]. The effects of TNF-a on S.
mansoni metabolism, development and egg-laying process have
been described a long time ago [6–8]; Amiri et al reported that
TNF-a induces liver granulomas and egg-laying of parasites in vivo
[6]; additionally, Cheever et al [8] observed that egg laying and
fecundity were delayed when SCID immuno deficient schisto-
some-infected mice were studied, suggesting the possibility that the
delay in fecundity is due to a delay in tissue produced TNF-a in
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that TNF-a alone can reconstitute early fecundity in this infected-
mouse model [8]. Conversely, Haseeb et al showed that in S.
mansoni females the egg-laying process is decreased and tyrosine
up-take is increased in the presence of TNF-a [7]. There is
controversial evidence of TNF-a influence on the parasite’s
metabolism, and the molecular mechanisms of its action have
never been explored.
The TNF receptor (TNFR) superfamily comprises membrane
bound or soluble receptors which interact with one or more
specific ligands. Currently more than 40 members of the TNFR
superfamily have been identified in humans [9]. The TNF-like
receptors are transmembrane proteins characterized by extra-
cellular Cysteine-Rich domains (CRD) that are the hallmark of the
TNFR superfamily. These pseudo-repeats are defined by in-
trachain disulphides, typically having highly conserved cysteine
residues within the receptor chains. Significant variation in the
number of CRDs exists among the receptor family members, with
the most common structure bearing four CRDs and other
members having from one up to six CRDs [9–11]. TNFR
superfamily can be divided into three groups: (i) the death
receptors, which mediate cell death through their cytoplasmic
Death Domain, with TNFR1 as the typical member; (ii) the non-
death receptors, which signal mostly through one or more of the
TNF receptor-associated factors (TRAFs), TNFR2 being the
typical member; and (iii) decoy receptors which bind TNF-related
apoptosis-inducing ligands but may prevent ligand-mediated
apoptosis through a number of different mechanisms [12]. Until
this moment, no member of the TNFR superfamily has ever been
described in S. mansoni.
Recent advances on schistosome genomics have led to
considerable progress in understanding of the complex molecular
mechanisms controlling the life cycle of this helminth parasite.
Publication of large-scale sequence databases of both S. mansoni
and S. japonicum transcriptomes in 2003 provided the first large
repository of schistosome genes and brought insights into several
aspects of schistosome biology [13,14]. A large-scale joint effort to
sequence the S. mansoni genome is under way [15,16] and a draft of
the assembled sequences is accessible at the project website. One
of the post-genomic approaches that have been explored in
schistosomes is the use of microarrays to perform large-scale
studies of gene expression at different stages of the life cycle
[17–20] and gender associated expression profiles [21–25].
However, no studies have looked at the effect of hormones or
cytokines on large-scale gene expression in the parasite.
In the present work we describe the homolog to human TNF-a
receptor and the possible TNF-a downstream signaling pathway
elements in S. mansoni; we also evaluate the in vitro effect of human
TNF-a on the gene expression profile of S. mansoni adult parasites
along with the effect of TNF-a on schistosomula just 3 hours after
cercariae-to-schistosomula in vitro transformation.
Materials and Methods
Amplification of SmTNFR transcript by PCR and RACE
experiments
Total RNA (1 mg) was extracted from BH strain adult worms
using Trizol reagent (Invitrogen, Life Technologies Inc., Carlsbad,
CA, USA) and then treated with DNAse I (QIAGEN, Hilden,
Germany). Total RNA was used for reverse transcription with
SuperScript III First Strand Synthesis SuperMix (Invitrogen),
using 50 ng of random hexamers according to manufacturer’s
instructions. The PCR step was performed with Advantage II
polymerase (Clontech, Mountain View, CA, USA) with buffer
supplied by the manufacturer, 2 ml of reverse transcription
reaction and 200 nM of each primer using the following program:
95uC (1min); 40 cycles of 95uC (30 s), 49 to 57uC (30 s), depending
on the primer pair combination used, and 68uC (5min); final
extension of 68uC (5min). Primers used are listed in Table S1,
part A.
Rapid Amplification of cDNA Ends (RACE) 39kit (Invitrogen)
and RACE 59kit (Invitrogen) were used according to manufactur-
er’s instructions. The PCR step was performed as described above.
Products from all PCR experiments were cloned into pGem-T
vector (Promega, Madison, WI, USA) transformed into E. coli and
stocked in TB-ampicillin. Selected clones were sequenced and the
sequences were analyzed and assembled using PhredPhrap
program [26]. The resulting SmTNFR sequence has been
deposited in GenBank with accession number GQ222226.
Real-time RT-PCR experiments
Total RNA (3 mg) from each sample was treated with DNAse I
(QIAGEN) and purified using RNeasy Mini kit (QIAGEN)
according to the manufacturer’s instructions. 1.5 mg of total
RNA were used as template to perform reverse transcription with
random hexamer primers, 200 units of SuperScript III (Invitrogen)
reverse transcriptase for 10 min at 25uC, 50 min at 50uC followed
by 5 min at 85uC. 1 ml of Rnase H was added to the reaction and
incubated for 20 min at 37uC. A parallel negative control reaction
was carried out with addition of all components except reverse
transcriptase. Each resulting cDNA sample was assayed by real-
time PCR in triplicate reactions using gene-specific primers that
were designed with the Primer Express program (V2.0) with
default parameters (Applied Biosystems, Life Technologies Inc.,
Carlsbad, CA, USA). Reactions were carried out with SybrGreen
PCR core reagent (Applied Biosystems) for 40 cycles in a volume
of 20 ml and according to the manufacturer’s instructions using the
GenAmp5700 sequence detector (Applied Biosystems). Tubulin
was used as internal standard gene in expression measurements
among parasite’s life cycle stages. Gene specific primers used are
described in Table S1, part A. The results were analyzed by
Author Summary
Schistosoma mansoni is the major causative agent of
schistosomiasis in the Americas. This parasite takes
advantage of host signaling molecules such as cytokines
and hormones to complete its development inside the
host. Tumor necrosis factor-alpha (TNF-a) is one of the
most important host cytokines involved in the inflamma-
tory response. When cercariae, the infective stage,
penetrates the human skin the release of TNF-a is started.
In this work the authors describe the complete sequence
of a possible TNF-a receptor in S. mansoni and detect that
the receptor is most highly expressed in cercariae among
all life cycle stages. Aiming to mimic the situation at the
site of skin penetration, cercariae were mechanically
transformed in vitro into schistosomula and exposed to
human TNF-a. Exposure of early-developing schistosomula
to the human hormone caused a large-scale change in the
expression of parasite genes. Exposure of adult worms to
human TNF-a caused gene expression changes as well,
and the set of parasite altered genes in the adult parasite
was different from that of schistosomula. This work
increases the number of known signaling pathways of
the parasite, and opens new perspectives into under-
standing the molecular components of TNF-a response as
well as into possibly interfering with parasite–host
interaction.
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among expression changes in the expression level was calculated
using ANOVA followed by Tukey Range Test [28].
In silico analysis of members of TNF-a signal transduction
pathway in S. mansoni
Human protein sequences of TNF-a signal transduction
pathway elements were used as queries to perform a search
in the S. mansoni genome (downloaded from the Sanger Insti-
tute website; ftp://ftp.sanger.ac.uk/pub/pathogens/Schistosoma/
mansoni/genome) using the locally installed copy of the genome
sequence and the tBLASTn algorithm. A similar search with
Blastp was performed against gene predictions at Schisto GeneDB
website (available at http://www.genedb.org/genedb/smansoni).
S. mansoni ESTs available at GenBank were assembled into EST
contigs with Cap3 [29] (contig sequences are available in a
FASTA format in supplementary File S1) and were searched with
Human protein sequences of TNF-a signal transduction pathway
elements as queries, using tBLASTn algorithm. The S. mansoni
contig sequences obtained or their translated sequences were
queried back to the GenBank protein dataset with BLASTx or
BLASTp in order to confirm their identities with the respective
element used for the initial search. Sequences with BLASTx or
BLASTp best hit e-value,10
25 were considered as putative S.
mansoni homologs of TNF-a signaling elements. For SmTNFR
translated protein, a signal peptide was predicted with SignalP
algorithm [30] and transmembrane helix domains were predicted
with the TMHMM-2.0 algorithm [31] available at http://www.
cbs.dtu.dk/services/TMHMM-2.0/. Conserved protein domains
were identified using PFAM algorithm [32] (available at http://
pfam.sanger.ac.uk/), Interpro algorithms [33] (available at http://
www.ebi.ac.uk/Tools/InterProScan/) and SMART database [34]
(available at http://smart.embl-heidelberg.de/).
Phylogenetic analysis of TNFR/NGFR sequences
Sequences corresponding to the TNFR conserved domain
(cd00185) from 17 different species were aligned along with
SmTNFR sequence using ClustalX. Sequence alignment was
imported to MEGA 4.0 [35] and the evolutionary history was
inferred using the Neighbor-Joining method. The percentage of
replicate trees in which the associated taxa clustered together in
the bootstrap test (100 replicates) was calculated. Evolutionary
distances were computed using the Poisson correction method and
are in the units of the number of amino acid substitutions per site.
All positions containing gaps and missing data were eliminated
from the dataset (Complete deletion option). There were a total of
96 positions in the final dataset. Accession numbers for the
sequences used in the alignment are: AAX43474, NP_035741.2,
XP_522334.2, NP_777099.1, AAA40465.1, NP_001025950.1,
EDL29730.1, NP_001035580.1, NP_001057.1, XP_548191.2,
NP_001095948.1, AAD17943.1, P18519.1, XP_001339291.2,
XP_002224391.1, XM_001625712.1, FF473364.1.
Schistosomula and adult worm in vitro treatment with
human TNF-a
Schistosomula were obtained by mechanical transformation as
described by Basch et al [36], transformed schistosomula were
incubated during 3 h (37uC, 5% CO2) in 11 ml M-169 medium
containing 10% bovine fetal serum. Then 20 ng/ml human TNF-
a (Sigma; stock solution dissolved at 100 mg/ml in 10 mM Tris-Cl
pH 8.0) were added to the cultures according to [7] and incubated
during 1 h (37uC, 5% CO2). Negative control schistosomula were
incubated in parallel in 11 ml M-169 containing 10% bovine fetal
serum with the vehicle (2.2 mL 10mM Tris-Cl pH8.0). Three
independent biological replicas of schistosomula treated with
human TNF-a during 1 h with respective control were obtained
(in a total of 6 samples).
Adult parasites were obtained from portal vein perfusion of
hamsters 7–8 weeks after infection. After perfusion the worms
were washed in PBS and only paired worms were incubated
during 1 h, and 24 h (37uC, 5% CO2) in 30 ml RPMI containing
10% bovine fetal serum with 20 ng/ml human TNF-a (Sigma,
stock solution dissolved as before) in parallel with negative control
worms (incubated in 30 ml RPMI containing 10% bovine fetal
serum with the vehicle, 6 mL 10mM Tris-Cl pH8.0). Three
independent biological replicas were obtained for each experi-
mental time with respective controls (in a total of 12 samples).
Infected hamsters were maintained at Instituto Adolfo Lutz that
approved the study, and the experimental procedures were
conducted adhering to the institution’s guidelines for animal
husbandry.
Total RNA extraction and microarray experiments
Total RNA was extracted using Trizol reagent (Invitrogen)
according to the manufacturer’s instructions. After Trizol
extraction RNAs were treated with DNAse I (QIAGEN) and
subsequently purified using RNA easy mini kit (QIAGEN). The
integrity of RNA samples was evaluated using microfluidic
electrophoresis in the Bioanalyzer equipment (Agilent Technolo-
gies, Santa Clara, CA, USA).
The oligoarray platform used in this work was previously
described by Verjovski-Almeida et al [37] for the experiments
using adult worm samples. A new platform, 4644k, containing
the same probe set, but a different control set was used for the
experiments with 3-hour old early schistosomula. For each of the
two platforms, the control set is the one recommended by Agilent,
according to the probe disposition on the array. The platforms
contain the same set of 44000 oligonucleotide probes that were
designed by our group to represent all S. mansoni gene fragments
available in the public GenBank database; slides were manufac-
tured for us by Agilent Technologies. The microarray platform
design along with gene annotation names was deposited at NCBI
gene expression omnibus (GEO) under accession numbers
GPL4791 (1644K) and GPL8606 (4644K). MIAME compliant
data were deposited under accession numbers GSE16261 (adults)
and GSE16260 (schistosomula). Table S1, part B contains the
oligoarray probe numbers, the corresponding ESTs contig
represented by each probe, the predicted protein Smp_xxxxxx
number when available (see annotation method below), and the
putative human homolog (E-value ,1e-20) Accession number
when available (see below).
Either 230 ng from each RNA sample of schistosomula treated
for 1 h and their respective control or 300 ng from each RNA
from paired adult worms treated for 1 h and 24 h with human
TNF-a and their respective negative controls were used for
labeling with the Linear RNA amplification and labeling kit
(Agilent Technologies) according to manufacturer’s instructions.
Each sample was separately labeled with either Cy3 or Cy5 and
825 ng cRNA from each amplification were used for hybridiza-
tion; in experiments with schistosomula a control sample was
combined with a treated sample and hybridized; in experiments
with adult worm samples Self-Self hybridizations were performed
[38]. Washing and scanning procedures were according to the
manufacturer’s instructions using GenePix 4000B scanner (Mo-
lecular Devices, Sunnyvale, CA, USA). Data was extracted using
Feature Extraction software (Agilent Technologies).
Schistosoma mansoni TNF-Alpha Receptor Gene
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Low intensity data points were filtered out according to Feature
Extraction software criteria, which essentially determine those
points that are significantly below the average background signal
of the array. Total intensity data from each experiment were
normalized by Quantiles Normalization Method [39], excluding
positive and negative external controls. For both experiments
(treated schistosomula and treated adult paired worms) Signifi-
cance Analysis of Microarray (SAM) was used as the statistical test
to identify differentially expressed genes [40]. For schistosomula,
we performed a z-score transformation of normalized data was
performed [41] and SAM two class tests were applied; genes were
considered as significantly differentially expressed at q-value #0.05.
For adult worms, we calculated a virtual Log2 ratio between
intensities of TNF-a Treated/Control, for each gene. With these
ratios, we used two different approaches for SAM statistical
analyses. SAM one-class approach was used to identify genes with
sustained changes in their expression levels along the entire time
period of observation (1 and 24 h); SAM two-class approach was
used to identify genes with transient changes in their expression
levels. In both cases, genes were considered differentially expressed
at q-value #0.05. Hierarchical clustering of selected genes was
generated using Spotfire Decision Site software (TIBCO Software
Inc., Palo Alto, CA, USA). For a gene that was represented in the
array by multiple probes, we picked a single representative probe
by selecting the probe with the highest absolute value of the Log2
ratio between intensities of TNF-a Treated/Control.
Gene ontology terms were assigned to genes represented in the
array as described by Verjovski-Almeida et al [37]. GO terms
enrichment was calculated using Ontologizer program [42]. The
p-values were adjusted for multiple comparisons using the
Benjamini-Hochberg method.
Ingenuity Pathway Analysis software was used for identifying
significantly enriched gene networks among the differentially
expressed S. mansoni genes. For this purpose, S. mansoni genes
encoding putative homologues to human proteins were identified
in the following way. A search of each S. mansoni ESTs contig
against the gene prediction data set on GeneDB was performed
(cutoff =.90% identity and over 20% coverage of the contig) and
a total of 15491 contigs could be associated to Smp_xxxxxx
predictions. The 15491probes, representing each of these contigs,
correspond to 39% of the 39343 probes on the oligoarray; they
comprise a set of 7480 unique Smp entries. Next, the sequence of
each of these Smp predictions was aligned to the GenBank human
proteins dataset (using BLASTp), with a BLASTp cutoff e-value
#1610
220; a total of 10036 out of the 15491 probes on the
oligoarray that represent S. mansoni predicted proteins were
associated to human proteins (Table S1, part B). This set of
probes represents 3736 unique human protein-coding genes. The
GI number of each human protein putative homolog was
associated to the correspondent S. mansoni probe (see Table S1,
part B) and the expression data was up-loaded to Ingenuity
Pathway Analysis System version 7.6.
Results
Identification of S. mansoni TNF-a receptor gene
sequence
Human TNF-a receptor sequence NP_001057.1, tumor necrosis
factor receptor 2 precursor [Homo sapiens] was used as query to
perform an in silico tBLASTn search in the S. mansoni genomic DNA
sequence downloaded from Welcome Trust Sanger Institute ftp
website. With this approach we found genomic scaffold
Smp_scaff000357 that contains a 150 bp sequence (from position
38758 to 38907) with 42% identity and 54% similarity to human
tumor necrosis factor receptor 2 precursor (NP_001057.1) from
aminoacid positionsArg-141toAla-189.Uponcloseinspectionand
a cross reference to protein sequence predictions at Schisto GeneDB
website (http://www.genedb.org/genedb/smansoni/), a gene pre-
diction (Smp_168070) with a partial sequence was found in scaffold
Smp_scaff000357 (see scheme in Figure 1), annotated as ‘‘tumor
necrosis factor receptor related’’. This was the only TNF-a receptor
sequence found in the entire genome. The 59-end of this prediction
was incomplete and did not contain sequence encoding all
extracellular-domain conserved elements of the TNF receptor
superfamily.Additionally,itslastexonwasnot correctlypredicted as
we will show below.
In order to obtain the complete TNF-a receptor sequence in S.
mansoni we designed three different experiments using total RNA
or mRNA as template: (i) cloning the 59end by 59-Rapid
Amplification of cDNA Ends (59-RACE) extension (primers used
are identified in Figure 1 as arrows 1 and 2), complemented by
PCR reactions with a reverse primer based on the sequence of 59-
RACE extension (primers 3 and 4) and a forward primer based on
upstream genome sequence in relation to the 59end of the RACE-
extended message (primers 5 to 7); (ii) cloning the central region
based on the predicted Smp_168070 gene sequence and the 59-
RACE extended sequence (primers 8 and 9); and (iii) extending the
39end by performing 39-RACE experiments (primers 10 to 12 plus
adaptor reverse primer supplied with the RACE kit). Table S1,
part A contains all primers used in these experiments.
The assembled cDNA sequence obtained from all the above
experiments resulted in a 1967 bp transcript that was named
SmTNFR (Figure 1). The full-length transcript matches perfectly
(with exception of bases 1954 and 1958) to the genome sequence
in scaffolds Smp_scaff001950 and Smp_scaff000357. Based on the
alignment regions we concluded that the SmTNFR transcript is
composed of 7 exons.
The first exon has 408 bp and aligns with genome scaffold
Smp_scaff001950 (between coordinates 84375 to 84782 in the
minus strand; therefore, for clarity this scaffold is pictured in
Figure 1 as the reverse-complement). The second exon has 207 bp
(from base 409 to 615 of assembled cDNA) and aligns with
genome scaffold Smp_scaff000357 (between coordinates 38695 to
38901 in the plus strand). The third exon has 143 bp (616 to758)
and it aligns with the same genomic scaffold between coordinates
39254 to 39396. Exon number four is 206 bp in length (base 759
to 964 of assembled cDNA) and matches the genome sequence
between coordinates 41864 to 42069); exon 5 has 441 bp (base
965 to 1405 of assembled cDNA) that matches with genomic
coordinates 60952 to 61392; exon 6 has 102 bp (1406 to 1507 bp)
and aligns to the genomic scaffold from 61778 to 61879; finally the
last and longest exon number 7 has 460 bp and aligns to the
genomic scaffold from 62996 to 63467. Donor and acceptor
splicing sites are the canonical GT/AG bases for all intron-exon
junctions.
Curiously, the genomic sequence between coordinates 63139
and 63202, corresponding to a region within exon 7, is composed
of 11 copies of a three-base simple sequence repeat (with sequence
AAT). Upon aligning the assembled cDNA to genome scaffold
Smp_scaff000357 a gap was detected from 63139 to 63150, which
in the genome sequence corresponds to 4 out of the 11 AAT
repeats. Consequently, we concluded that our cDNA sequence
lacks 4 of the 11 AAT repeats, being characteristic of the parasite
BH strain used in the laboratory, which is different from the
Puerto Rican strain used for genome sequencing (http://www.tigr.
org/tdb/e2k1/sma1/intro.shtml). In addition, cDNA bases 1954
and 1958 at the very 39-end of our cloned cDNA are the only two
Schistosoma mansoni TNF-Alpha Receptor Gene
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are A’s that come from the poly-dT-adaptor reverse primer used
for the 39-RACE and in the genome we found T and G in the
respective positions. As discussed later, an internal priming of the
message has probably occurred during reverse-transcription at the
cDNA synthesis step.
Identification of S. mansoni TNF-a receptor conserved
domains
The translated sequence encodes a complete TNFR protein
with 599 amino acids, predicted by ORF finder, shown in the
scheme of Figure 1. A second Met-22 is present in the SmTNFR
translated sequence, 21 amino acids downstream of the predicted
ORF start (marked by a dotted vertical line in the purple block,
Figure 1); in case that translation eventually starts there, the
receptor would be shorter, with 578 amino acids in length.
A signal peptide was predicted with SignalP 3.0 [30]. For the
longer sequence, using the Neural Networks (SignalP-NN)
algorithm a signal peptide was predicted within the first 43 amino
acids of SmTNFR (max S-score=0.918; D-score=0.436). The
SignalP Hidden Markov Model (SignalP-HMM) was not able to
find a signal peptide motif. For the shorter sequence, SignalP-NN
predicted a signal peptide within the first 22 amino acids (max S-
score=0.971; D-score=0.826); SignalP-HMM predicted the
same signal peptide (p=0.980), within the first 22 amino acids.
In all cases, the predicted signal peptide cleavage site is between
Ala and Gly residues within the VIA-GPL sequence motif; in the
longer sequence the most likely cleavage site is between positions
Ala-43 and Gly-44 (SignalP-NN cleavage site C-score=0.521). In
the alternative shorter sequence, the same cleavage site would
correspond to positions Ala-22 and Gly-23 in a re-numbered
sequence (SignalP-NN cleavage site C-score=0.923; SignalP-
HMM cleavage site probability p=0.967). The signal peptide is
indicated in purple in the scheme of Figure 1. Using the
TMHMM-2.0 algorithm, a transmembrane helix domain was
predicted within the signal peptide domain (see yellow hatched
box, in the scheme of Figure 1) from amino acids Val-27 to Ile-47
(max membrane probability p=0.754), thus defining a predicted
extracellular N-terminal domain that extends from Gly-44 to Asn-
304 in the mature protein, following signal peptide cleavage. A
second transmembrane helix domain (yellow box, in the scheme of
Figure 1) was predicted from amino acids Gln-305 to Tyr-327
(max membrane probability p=0.945), using the TMHMM-2.0
algorithm.
Four TNFR/NGFR domains (Cystein-Rich Domains, CRD)
(green boxes in the scheme of Figure 1) were predicted in the
extracellular region; these domains were found by PROSITE
(PS50050, TNFR_NGFR_2 cysteine-rich region domain) between
amino acids Cys-103 to Cys-142 (score=10.108), Pro-144 to Cys-
188 (score=11.670), Gln-189 to Cys-227 (score=10.943) and Ser-
229 to Cys-269 (score=11.371).
The intracellular region of the predicted protein encoded by
SmTNFR is composed of the C-terminal 272 amino acids
extending from Lys-328 to Asn-599 (see scheme in Figure 1);
no conserved protein domain could be identified in this region,
suggesting that SmTNFR belongs to the group of TNFR-
superfamily members such as TNFR2 that typically lack the C-
terminal Death-Domain motif.
SmTNFR highest similarity to a human TNF-family member is
with Tumor necrosis factor receptor superfamily, member 5
isoform 1 precursor, usually called human CD40 (P25942.1,
TNR5_HUMAN), a non-death domain receptor, with E-
value=4610
29, 51% similarity and 32% identity over 57% of
the Homo sapiens protein sequence; highest sequence similarity was
present at the 59-end of the gene, which encodes the conserved
ligand-binding N-terminal extracellular domain. According to
Figure 1. Schematic representation of SmTNFR gene and respective ORF. Each gray bar represents an exon and its respective localization in
genome scaffolds is shown. SmTNFR gene is encoded in the Plus strand. The hatched bar represents the original Smp_168070 in silico gene
prediction. The colored bars represent protein conserved domains of the ORF encoded by SmTNFR gene: Signal peptide region is shown in purple;
the white dotted vertical line marks the position of an internal Methionine residue near the translation start site; the yellow hatched lines mark the
transmembrane helical domain predicted at the signal peptide region; Gly-44 indicates the predicted start of the mature protein, when cleaved at the
predicted cleavage site, between Ala-43 and Gly-44; TNFR (green boxes) mark the Cystein Reach Domains, the hallmark of TNFR superfamily; TM,
Transmembrane helical domain. Numbered arrows indicate primers used in RACE and PCR experiments. Other three in silico predicted genes in this
region of the genome are all encoded in the Minus strand, and they are indicated by Smp_numbers.
doi:10.1371/journal.pntd.0000556.g001
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‘‘Tumor necrosis factor receptor superfamily’’ (TF331157) with
score 233.8. Analysis with Conserved Domain Database tools [44]
showed that SmTNFR has a complete Tumor Necrosis Factor
Receptor (TNFR) conserved domain (cd00185) (E-value=
5610
212).
A multi-sequence alignment of this conserved domain, including
invertebrate and vertebrate TNFR-family members, is shown in
Figure 2A, where it is seen that the complete conserved cystein-
rich TNFR motif is present in SmTNFR. A gene family tree is
shown in Figure 2B. It can be seen that SmTNFR is placed at a
basal position in relation to a branch that includes the vertebrate
TNFR1, TNFR2 and CD40 clades, and was separate from the
cluster of vertebrate and invertebrate NGFR-family members.
Expression levels of SmTNFR
Real-time RT-PCR experiments were performed to study the
expression level of SmTNFR among life cycle stages. Three
independent biological replicas from five different life cycle stages
were used (eggs, miracidia, cercariae, 7 day-old schistosomula and
adult worms). The highest expression of SmTNFR was detected in
cercariae (Figure 3), with 3.5 (60.7) times higher levels than in
adult worms, which exhibited the second highest expression. Eggs,
miracidia and 7-day old schistosomula had the lowest expression
levels of SmTNFR (Figure 3).
Identification of TNF-a signaling pathway elements in S.
mansoni
Human TNF-a receptors interact with cytoplasmic proteins that
activate a signaling cascade composed of multiple protein kinases.
In order to evaluate if the TNF-a signal transduction pathway is
conserved in S. mansoni, we performed an in silico analysis using
human protein sequences described as involved in the canonical
TNF-a signaling pathway [45], aiming to find conserved signaling
elements between S. mansoni and human.
We found S. mansoni genes potentially encoding 9 signaling
elements that participate in the human TNF-a signaling pathway
that is activated by TNFR2 (the TNFR group that does not
contain the intracellular C-terminal Death Domain). Figure 4
shows a schematic representation of TNF-a signal transduction
pathway conserved elements in S. mansoni. Table S2 contains
specific alignment and similarity parameters for each component,
including ESTs contigs, gene predictions, mRNAs that encode
sequences with similarity to the human proteins and the S. mansoni
genomic scaffolds where these elements are located. Human
TNFR2-activated pathway involves a conserved signaling cascade
composed of protein kinases (Figure 4). The human receptor
interacts with TRAF2 that will activate MAPKKK, which in turn
activates JNKK; the latter activates JNK that will phosphorylate
and activate c-JUN transcription factor in the nucleus. Homologs
of all these elements were found in S. mansoni (Figure 4).
Phosphorylated c-JUN promotes transcription of target genes in
the TNF-a signaling pathway. We also found a possible ortholog
to A20-like protein (A20-L, Traf-Binding Domain-Containing
Protein; TRABID), a protein that interacts with TRAF, along with
orthologs to c-IAP (cellular inhibitor of apoptosis protein 1/2), and
to caspase-3 and caspase-8, which are related to apoptosis in
human cells, especially when activated by signaling through
TNFR1.
We note that human MAPKKK is the most difficult element in
the pathway for which to predict an ortholog in S. mansoni because
it refers to two similar kinases, namely MEKK1 (also known as
MAPKKK1) and MEKK5 (also known as ASK1 or MAPKKK5),
and there are still other very similar MAP kinases [46]. Human
MAPKKK5 best hit against S. mansoni gene prediction is
Smp_162800.1, annotated as ‘‘protein kinase’’, with E-value=
3610
2156, 36% identity, 56% similarity, and 64% coverage of the
human MAPKKK5. The best human hit of Smp_162800.1
against GenBank is MAPKKK15, with E-value=1610
2160, 39%
identity, 59% similarity, and 64% coverage, while MAPKKK5 is
only the second best human hit against GenBank. BLAST search
of GenBank using contig C911313.1 gives the same MAPKKK15
and MAPKKK5 hits, although with lower scores than for the full-
length predicted S. mansoni protein (Table S2). We propose that
the MAPKKK homolog found in S. mansoni could activate JNKK
because of the overall context of other signaling elements.
Effects of human TNF-a on gene expression profile in S.
mansoni schistosomula
In order to find the possible target genes of SmTNFR signaling
pathway we performed microarray experiments with S. mansoni
parasites treated in vitro with human TNF-a.
In the first set of experiments, cercariae were in vitro transformed
into schistosomula by mechanical removal of their tails [36], and
incubated for three hours at 37uC for recovery. Human TNF-a
(20 ng/ml) was added to these recently transformed schistosomula,
in an attempt to mimic the exposure to TNF-a upon penetration
of the human skin. We chose to use the same TNF-a
concentration that was previously used in the literature [7] for in
vitro experiments with adult parasites. The 3-hour old early
schistosomula were incubated during 1 h with TNF-a; in parallel a
negative control was maintained in the absence of cytokine. Three
independent replicate experiments were performed. RNA was
extracted from TNF-a treated and non-treated early schistosom-
ula, and processed for microarray hybridization.
A set of 755 probes was identified with a statistically significant
(q-value ,0.05) differential expression between TNF-a treated and
control early schistosomula (Figure 5). These probes represent
548 unique genes; among them, 309 were induced and 239 were
repressed in presence of human TNF-a. Table S3 shows the
number of differentially expressed genes for this 1h-treatment,
according to the three annotation categories: S. mansoni genes with
orthologs in other species, S. mansoni genes with orthologs only in S.
japonicum and in no other species, and S. mansoni genes with no
similarity in GenBank (NoMatch). Table S4 contains the list of
differentially expressed genes.
S. mansoni genes represented in the microarray were automat-
ically annotated with gene ontology (GO) terms [47]. The
Ontologizer program [48] was used for highlighting gene
ontologies that were significantly over-represented in the set of
genes differentially expressed between 1h-treated and control
parasites (Table 1). Categories involved in the translation process
such as ribosomal proteins and proteins from the pyruvate
dehydrogenase complex were identified as over-represented in
genes with higher expression in TNF-a 1h-treated schistosomula.
In an opposite group, i.e. genes with higher expression in TNF-a
non-treated schistosomula (control parasites), enrichment of GO
category involved in the molecular function ‘‘nucleotide binding’’
(GO: GO:0000166) was observed. Table S5 shows the names of
the differentially expressed genes found in each category.
In order to identify the possible networks of interaction among
the significant differentially expressed genes we used the Ingenuity
Pathway Analysis software. The most significantly enriched
(p=10
229) network comprising differentially expressed genes in
1h-treated schistosomula is shown in Table 2. Genes belonging to
this enriched network are involved with the following functions:
Gene Expression regulation (p-value,2.7610
22), Cellular growth
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www.plosntds.org 6 December 2009 | Volume 3 | Issue 12 | e556Figure 2. Phylogeny tree of the tumor necrosis factor receptor superfamily. Sequences corresponding to the TNFR conserved domain
(cd00185) were (A) aligned using ClustalX, and (B) the evolutionary history of the protein family was inferred using the Neighbor-Joining method, as
described under Methods. The percentage of replicate trees in which the associated taxa clustered together in the bootstrap test (100 replicates) is
shown for each tree branch. Accession numbers for the sequences used in the analyses are given under Materials and Methods.
doi:10.1371/journal.pntd.0000556.g002
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22), Cell cycle (p-value,
2.5610
22) and Cellular development (p-value ,2.5610
22).
Effects of human TNF-a on gene expression profile in S.
mansoni adults
In a second set of experiments, paired adult worms freshly
recovered from portal perfusion of infected hamsters were
incubated with human TNF-a for 1, 6 or 24 h. Two different
patterns of expression were detected: a transient change and a
sustained change in expression throughout the entire time of
exposure to TNF-a.
A set of 1594 probes that represent 1365 unique genes revealed
statisticallysignificant (q-value#0.05)transient changesinexpression.
Among them, 821 genes were induced by TNF-a in 1 h and
repressed after 24 h of treatment, and 544 have the opposite pattern
(Figure 6A).TableS6shows the number of differentially expressed
genes according to the three annotation categories: S. mansoni genes
with orthologs in other species, S. mansoni genes with orthologs only
in S. japonicum and in no other species, and S. mansoni genes with no
similarity in GenBank (NoMatch). Table S7 contains the list of
differentially expressed genes that showed transient changes.
A search for enriched Gene Ontology (GO) terms associated to
the transiently affected genes was performed. Significantly
enriched GO terms were found in the sets of genes induced by
TNF-a in 1 h (Table 3). Genes with induced expression in 1 h of
treatment belong to categories related to translation. Table S8
identifies the genes found in these categories.
Using Ingenuity Pathway Analysis we identified that the most
significantly enriched (p=10
259) network with transient changes
in expression in adult worms is comprised of genes related to
these functions: cellular assembly and organization (p-
value,2.2610
22), RNA post-transcription modification (p-
value,1.1610
22), Protein synthesis (p-value,1.03610
22), Cell
morphology (p-value,4.6610
22), Gene Expression (p-value,
3.2610
22), Cell cycle (p-value,4.1610
22). Table 4 lists the
genes involved in these functions and Figure S1 shows a
schematic representation of network interactions.
A sustained pattern of expression change in adult worms
throughout the 24 h of observation was detected for another set of
genes, when treated with human TNF-a (Figure 6B). A total of 626
probesthat represent 492 geneshad a sustained change in expression;
among them, 336 were induced and 155 repressed byTNF-a.Table
S9 shows the number of differentially expressed genes according to
the three different annotation categories: S. mansoni genes with
orthologs in other species, S. mansoni genes with orthologs only in S.
japonicum and in no other species, and S. mansoni genes with no
similarity in GenBank (NoMatch). Table S10 contains the list of
geneswithsustained changesin theirexpressionlevels.Amongtheset
of repressed genes an enriched GO category related to ‘‘nucleotide
metabolic process’’ (GO: 0000166) was enriched (Table 3). The list
of genes found in this category is shown in Table S8.
Using Ingenuity Pathway Analysis we identified that the most
significantly enriched (p=10
229) network with sustained changes
in expression throughout the 24 h of treatment in adult worms is
comprised of genes related to these functions: molecular transport
(p-value,1.3610
22), Nervous System Development (p-value,
1.23610
22), Tissue morphology (p-value,3.8 610
22), Nucleic
Acid metabolism (p-value,1.1610
22), lipid metabolism (p-
value,1.36 610
22), Cellular assembly and organization (p-
value,1.0 610
22), Cell morphology (p-value,1.2 610
22) and
Cell signaling (p-value,1.3 610
22). Table 5 lists the genes
involved in the above functions.
Figure 7 shows a schematic representation of network interactions
for the genes with a sustained pattern of expression change in adult
worms throughout the 24 h of observation that belong to the most
significantly enriched (p=10
229) network. It is interesting to note that
one of the nodes in the network is centered at TNF-a.N oe v i d e n c ei s
found for a S. mansoni TNF-a gene in the transcriptome or genome.
Figure 3. Relative expression levels of SmTNFR among five S. mansoni life cycle stages. The different bar colors indicate three independent
biological replicas. The expression levels of egg stage were arbitrarily set as 1, and values for other stages are represented as fold changes relativet o
this value, within the corresponding biological replica. Bars represent standard deviation of the mean for three technical replicates within each
biological replica. Tubulin was used as internal normalization gene. ANOVA was used for calculating the statistical significance of expression changes
among all life cycle stages (p-value ,0.0001). Tukey test was used to calculate the significance between two life cycle stages. * p-value ,0.01
between cercaria and egg, cercaria and miracidium, cercaria and schistosomulum and cercaria and adult comparisons.
doi:10.1371/journal.pntd.0000556.g003
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downstream targets of added human TNF-a are analogous to the
known target genes affected by this cytokine in humans.
By comparing the lists of differentially expressed genes in early
schistosomula and in paired adult worms, we found only 73
probes, representing 58 genes in common. Table S11 shows these
58 genes and their expression pattern in each experiment. The
very small fraction of differentially expressed genes affected in
common in both early schistosomula and adult worms (11% and
3%, respectively) indicates that S. mansoni TNF-a response is stage
specific; probably some additional elements might have emerged
and have been incorporated into the signal transduction pathway
during host-parasite co-evolution, causing the activation of
different stage-specific target genes.
Discussion
Our results indicate that the SmTNFR identified in the present
work is a possible S. mansoni homolog to human TNFR. The
possible conserved elements of a complete TNF-a signal
transduction pathway were in silico identified in S. mansoni.I n
addition, our microarray results show different sets of target genes
that are transcriptionally activated by TNF-a signaling in the two
different developmental stages studied.
SmTNFR identified in the present work is the only detectable
member of the TNF-receptor superfamily in the S. mansoni
genome. A phylogeny tree analysis suggested that SmTNFR is
orthologous to vertebrate TNFRs. Considering the tree topology,
SmTNFR represents an ancestral protein that diverged before the
formation of TNFR1, TNFR2 and CD40 families in vertebrates,
but after the divergence to NGFRs and other TNF-receptors.
Interestingly, due to its dissimilar distribution of introns [9] it has
been previously hypothesized that the NGFR gene has been
formed early in the evolution of TNFR superfamily.
Naismith et al. [49] developed a classification method for TNFR-
family extracellular cysteine-reach domains (CRDs) based on the
cysteine repeats: each CRD domain contains modules named
according to their type (A, B or C module) and the number of
Figure 4. Schematic representation of putative S. mansoni TNF signal transduction pathway. Orange elements were in silico identified in
S. mansoni, blue elements were not found. Symbol (R) indicates covalent modification : protein phosphorylation; (}) indicates non-covalent
interaction : association : protein/protein. Relations:( +), stimulatory; (2), inhibitory; (0), neutral; (?), undefined. Adapted from ref. [45]. Inside the
nucleus (rectangles) we have highlighted two examples of messages whose transcriptions are described in humans to be mediated by c-Jun.
doi:10.1371/journal.pntd.0000556.g004
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20 ng/ml human TNF-a just 3 h after in vitro mechanical transformation of cercariae. Microarrays were used for large-scale gene expression
measurements, and the figure shows a hierarchical clustering of the 548 genes that exhibited significant (q-value #0.05) changes in their expression
levels, in relation to control non-treated 3-h old early schistosomula. Each horizontal line represents a gene; each column represents one
experimental replica. There are two technical replicates for each of three biological replicates. For each gene, color intensity is proportional to the
number of standard derivations from the mean expression for that gene, as indicated in the scale bar, and shows genes that were induced (red) or
repressed (green) by treatment.
doi:10.1371/journal.pntd.0000556.g005
Table 1. Significantly enriched (p-value ,0.05) GO categories among the genes with higher expression in 3h-old early
schistosomula treated for 1 h with TNF-alpha.
Ontology GO term description GO term Counts p.adjusted
Genes with higher expression in treated schistosomula
cellular component ribosomal subunit GO:0033279 9/135 0.045
cellular component ribosome GO:0005840 10/164 0.045
biological process translation GO:0006412 10/272 0.045
cellular component pyruvate dehydrogenase complex GO:0045254 2/2 0.045
Genes with higher expression in non-treated schistosomula
molecular function nucleotide binding GO:0000166 20/242 0.021
doi:10.1371/journal.pntd.0000556.t001
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contain four A1 modules and four B2 modules that are combined in
a manner similar to the first two CRD domains of TNFR2
(Figure 8). Regarding the intracellular region, human NGFR and
TNFR1have a C-terminal Death-Domain motif, whereas SmTNFR
intracellular region lacks the conserved Death-Domain, indicating
that SmTNFR is a non-death receptor similar to human TNFR2
(Figure 8). The presence of Death-Domain motif in NGFR
orthologs is also observed in invertebrate protein sequences such as
in Branchiostoma floridae (XP_002224391.1). The absence of NGFR
homolog with a Death-Domain in S. mansoni and in other
invertebrates such as Drosophila melanogaster (accession numbers:
BAC01264.1 and AAM484141) and Caenorhabditis elegans (accession
numbers: AAP82639, AAB36865, NP_001024870 and
NP_001024869), but its presence in invertebrates of the Deuter-
ostomia groups suggests that this family of receptors may have been
lost in Protostomes. Interestingly, the cnidarian Nematostella vectensis
displays a TNFR with a Death-Domain (XP_001629570.1); the
available sequence is partial, lacking a portion of the N-terminal
extracellular region of the protein containing the TNFR conserved
domain(cd00185), which prevented us from addingthis sequenceto
our multiple alignment. However, analysis of the domain fragment
suggests that this protein forms a monophyletic group with the other
N. vectensis TNFR and is not closely related to any NGFR (data not
shown). Overall, data suggests that multiple events of acquisition or
loss of Death-Domains by TNFR/NGFR receptors must have
occurred during their evolution.
Human NGFR does not interact with bona fide TNFR ligands
and its only known interactions are to dimeric ligands of the
neurotrophin family [50]. In contrast, the CD40, TNFR1 and
TNFR2 receptors included in our phylogenetic analysis are able to
bind bona fide trimeric TNF ligands. The protein region chosen for
our evolutionary analysis includes the A1-B2-A1 modules
previously shown in this family of receptors to be responsible for
ligand interaction [49,51]. Therefore, it is possible to infer that
SmTNFR must be capable of binding bona fide TNF ligands.
We were unable to find any obvious gene homologs encoding
TNF-like ligands in the S. mansoni genome. The presence of a
single TNF-superfamily receptor in S. mansoni, along with the
observed effect of human TNF-a on the expression of a very broad
range of parasite genes with a stage-specific pattern, is a strong
suggestion that host TNF-a as well as other TNF-like ligands may
bind to SmTNFR and activate a canonical signal transduction
pathway in the parasite. This hypothesis is further supported by
the observation that human TNF- a treatment of S. mansoni adult
worms has induced a sustained change in expression of genes that
encode proteins belonging to a significantly enriched network that
comprises homologs to known human TNF-a interactors
(Figure 7). In this respect, we postulate that the minimal
downstream elements of the TNF-a signaling pathway are present
in the parasite (see below). Further experiments, involving
SmTNFR heterologous expression and direct ligand binding assays
are warranted to confirm this hypothesis.
The 59- and 39-end sequences of SmTNFR differ from the
predicted Smp_168070 gene. The 59-end sequence was obtained
by a combination of 59-RACE experiment and PCRs with cDNA
template and primers based on upstream genomic sequence. This
approach revealed SmTNFR first exon that contains the start
Table 2. Genes related to gene expression regulation, cellular growth and proliferation, cell cycle and cellular development that
comprise the most significantly enriched (p=10
229) network of differentially expressed genes in 1h-treated schistosomula.
Symbol Entrez Gene Name
Fold
Change
FDR
(%)
Sub-cellular
Location Gene family Probe Contig
LEO1 Leo1, Paf1/RNA polymerase II complex
component, gi:20270337
1.50 0.68 Unknown other Q2_P32546 C909180.1
PFDN5 prefoldin subunit 5, gi:22202633 21.27 1.17 Nucleus transcription
regulator
Q2_P25201 C809910.1
RPS8 ribosomal protein S8, gi:4506743 21.66 1.17 Cytoplasm other Q2_P19300 C801996.1
H2AFJ H2A histone family, member J,
gi:29553970
21.69 1.60 Unknown other Q2_P07060 C812342.1
PPP1R7 protein phosphatase 1, regulatory
(inhibitor) subunit 7, gi:4506013
1.29 2.44 Nucleus phosphatase Q2_P22537 C806375.1
EIF3M eukaryotic translation initiation factor
3, subunit M, gi:23397429
21.65 2.70 Unknown other Q2_P19683 C802459.1
THOC1 THO complex 1, gi:154448890 1.16 2.70 Nucleus other Q2_P19648 C802409.1
TAZ Tafazzin, gi:31317259 21.27 3.02 Nucleus enzyme Q2_P34715 C913170.1
ANAPC11 anaphase promoting complex subunit
11, gi:18777675
21.60 3.29 Cytoplasm enzyme Q2_P39504 JAP03774.C
RPL37 ribosomal protein L37, gi:4506641 21.67 3.29 Cytoplasm other Q2_P27341 C813404.1
GOT1 glutamic-oxaloacetic transaminase 1,
soluble, gi:4504067
1.37 3.57 Cytoplasm enzyme Q2_P26554 C812133.1
CDC23 cell division cycle 23 homolog (S.
cerevisiae), gi:118402596
1.78 3.76 Nucleus enzyme Q2_P18475 C800690.1
AGPAT9 1-acylglycerol-3-phosphate O-
acyltransferase 9, gi:21362092
21.24 4.49 Cytoplasm enzyme Q2_P06232 C811032.1
GGT7 gamma-glutamyltransferase 7,
gi:109148539
1.55 4.83 Unknown enzyme Q2_P27991 C901554.1
CSNK1D casein kinase 1, delta, gi:20149530 2.03 4.99 Cytoplasm kinase Q2_P26368 C811860.1
doi:10.1371/journal.pntd.0000556.t002
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proteins. The 39-end sequence was obtained through 39-RACE
experiments; the resulting sequence is different from gene
prediction Smp_168070 because in our cDNA the second to last
exon is longer than the predicted and we found that this was the
last exon (Figure 1). Therefore, the last exon of Smp_168070
Figure 6. Effect of human TNF-a on gene expression profile in adult worms. Paired adult worms were treated for 1 h and 24 h with 20 ng/
ml human TNF-a. Microarrays were used for large-scale gene expression measurements, and the figure shows the genes that exhibited significant (q-
value #0.05) changes in their expression levels, in relation to control non-treated paired adults. (A) Hierarchical clustering of 1365 genes with
transient changes in their expression levels. (B) Hierarchical clustering of 492 genes with sustained changes in their expression levels throughout the
24 h period of observation. Each horizontal line represents a gene, each column represents one experimental replica. There are two technical
replicates for each of three biological replicates, at each treatment time. Expression levels are indicated as the log2 ratio of intensities (Treated/
Control) for each treatment time (1 and 24 h). For each gene, color intensity is proportional to the log ratio as indicated in the scale bar, and shows
genes that were induced (red) or repressed (green) by treatment.
doi:10.1371/journal.pntd.0000556.g006
Table 3. Significantly enriched (p-value ,0.05) GO categories among the genes with altered expression in adult worms treated
with TNF-alpha.
Ontology GO term description GO term Counts p.adjusted
Genes with transient higher expression at 1 h treatment with respect to control
cellular component ribosome GO:0005840 23/144 6.47E-06
cellular component ribonucleoprotein complex GO:0030529 30/281 3.96E-05
cellular component cytosolic part GO:0044445 17/92 5.28E-05
cellular component ribosomal subunit GO:0033279 19/118 5.28E-05
molecular function structural constituent of ribosome GO:0003735 21/120 9.17E-04
cellular component macromolecular complex GO:0032991 58/1033 0.004948
molecular function structural molecule activity GO:0005198 23/255 0.004948
molecular function RNA binding GO:0003723 25/263 0.016548
biological process translation GO:0006412 23/257 0.017772
cellular component cytosol GO:0005829 20/199 0.025839
Genes with sustained lower expression (1 h and 24 h) in treated worms with respect to control
biological process nucleotide metabolic process GO:0009117 4/53 0.016505
doi:10.1371/journal.pntd.0000556.t003
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region: 64497 to 64519) had been wrongly predicted. Probably
SmTNFR cDNA 39-end is longer than we have obtained here,
because the poly-dT-Adaptor primer used in the cDNA synthesis
step of the 39-RACE experiment has annealed to an A-rich region
of the message. This can be determined by observing the genomic
sequence at the segment to which the cDNA 39-end is aligned.
This genomic sequence contains 12 A’s out of 14 bases from 63453
to 63467.
The eleven copies of the simple sequence repeat (SSR) detected in
genome scaffold Smp_scaff000357 were not observed in the cDNA
sequence; rather, only 7 repeats were present in the cDNA. The seven
AAT repeats occur inside the protein-coding region of the message
and will encode asparagine residues in the protein. Strand slippage at
Table 4. Genes that comprise the most significantly enriched (p=10
259) network of differentially expressed genes with transient
changes in their expression levels in adult worms treated with human TNF-alpha.
Symbol Entrez Gene Name
Fold
Change
FDR
(%)
Sub-cellular
location Family Probe Contig
ING4 inhibitor of growth family, member 4,
gi:189083828
21.39 0.00 Nucleus other Q2_P25301 C810038.1
NAT13 N-acetyltransferase 13 (GCN5-related),
gi:13376735
21.51 0.00 Cytoplasm enzyme Q2_P25057 C809706.1
PSMD8 proteasome (prosome, macropain) 26S
subunit, non-ATPase, gi:156631005
21.34 0.00 Cytoplasm other Q2_P22050 C805727.1
EIF1B eukaryotic translation initiation factor 1B
gi:5031711
21.31 0.67 Cytoplasm translation
regulator
Q2_P18585 C800830.1
TOLLIP toll interacting protein, gi:21361619 1.37 0.87 Cytoplasm other Q2_P06108 C810894.1
PSMB3 proteasome (prosome, macropain)
subunit, beta type, 3, gi:22538465
21.26 0.95 Cytoplasm peptidase Q2_P17899 C800020.1
RPL35A ribosomal protein L35a, gi:16117791 21.21 1.00 Cytoplasm other Q2_P32151 C908319.1
PDLIM1 PDZ and LIM domain 1, gi:13994151 1.23 1.14 Cytoplasm transcription
regulator
Q2_P25128 C809800.1
RPL13 ribosomal protein L13, gi:15431295 21.44 1.15 Cytoplasm other Q2_P25407 C810161.1
RPL11 ribosomal protein L11, gi:15431290 21.31 1.35 Cytoplasm other Q2_P20966 C804195.1
HTATIP2 HIV-1 Tat interactive protein 2, 30kDa,
gi:148728164
21.79 1.78 Nucleus transcription
regulator
Q2_P06098 C810883.1
MBTPS1 membrane-bound transcription factor
peptidase, site 1, gi:4506775
1.42 1.78 Cytoplasm peptidase Q2_P18217 C800380.1
LIMK1 LIM domain kinase 1, gi:4505001 21.78 2.20 Cytoplasm kinase Q2_P35970 C915732.1
PSMB2 proteasome (prosome, macropain)
subunit, beta type, 2, gi: 4506195
21.33 2.58 Cytoplasm peptidase Q2_P19420 C802139.1
DHX9 DEAH (Asp-Glu-Ala-His) box polypeptide 9,
gi:100913206
1.47 2.63 Nucleus enzyme Q2_P00121 C800369.1
RPL7 ribosomal protein L7, gi:15431301 21.44 2.85 Cytoplasm transcription
regulator
Q2_P19898 C802735.1
POLR2G polymerase (RNA) II (DNA directed)
polypeptide G, gi:4505947
21.56 3.12 Nucleus enzyme Q2_P33628 C911163.1
FBL fibrillarin, gi:12056465 21.59 3.86 Nucleus other Q2_P19894 C802728.1
MED10 mediator complex subunit 10, gi:49227854 21.39 3.86 Nucleus other Q2_P26815 C812517.1
NEDD8 neural precursor cell expressed, developmentally
down-regulated 8, gi:5453760
21.38 3.86 Nucleus enzyme Q2_P38356 C921416.1
RNMT RNA (guanine-7-) methyltransferase, gi:4506567 21.30 3.86 Nucleus enzyme Q2_P25200 C809909.1
AIMP1 aminoacyl tRNA synthetase complex-interacting
multifunctional protein 1, gi:45006986
21.42 4.44 Extracellular Space cytokine Q2_P02741 C805453.1
ALDH1B1 aldehyde dehydrogenase 1 family,
member B1, gi:25777730
1.46 4.81 Cytoplasm enzyme Q2_P19570 C802316.1
ATP2A2 ATPase, Ca++ transporting, cardiac
muscle, slow twitch 2, gi:4502285
1.42 4.81 Cytoplasm transporter Q2_P19618 C802376.1
CHMP1A chromatin modifying protein 1A, gi:103485496 21.30 4.81 Extracellular Space peptidase Q2_P15994 C916183.1
HIRA HIR histone cell cycle regulation defective
homolog A (S. cerevisiae), gi:21536485
1.38 4.81 Nucleus transcription
regulator
Q2_P18264 C800435.1
NHP2L1 NHP2 non-histone chromosome protein
2-like 1 (S. cerevisiae), gi:4826860
21.44 4.81 Nucleus other Q2_P00464 C801360.1
Fold change of expression at 24 h in relation to 1 h treatment.
doi:10.1371/journal.pntd.0000556.t004
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has been proposed to occur when DNA polymerase encounters
difficulty while replicating a repeat [52] and may result in diverse
human diseases. In bacteria, fungi and in kinetoplastids such as
Trypanosoma brucei the SSR expansion is described as a mechanism that
generates functional diversity [53]. The observed difference between
the S. mansoni strain sequenced by the genome project and the strain
used in this work, with the resulting change in the number of
asparagine residues at the intracellular protein domain, could alter the
receptor’s affinity to downstream signaling elements.
An interesting point of the present work is the in silico
identification of TNF-a signal transduction pathway elements in
S. mansoni. We were able to identify nine conserved elements
comprising a complete TNFR2-activated pathway (Figure 4)
[54]. Noteworthy is the fact that none of the downstream elements
that interact with the Death-Domain in the canonical vertebrate
TNFR1-activated or Neurotrophin/NGF-activated pathways
were identified in S. mansoni (Figure 4). Thus, similarly to the
vertebrate TNFR2, it is possible that SmTNFR intracellular region
interacts with TRAF (Figure 4). Interestingly, the JNK pathway
has been shown in D. melonagaster to be triggered by Eiger TNF
ligand [55]; JNK pathway elements are present in S. mansoni,
suggesting that Schistosomes may have a response to TNF ligands
analogous to that observed in Drosophila. The c-JUN transcription
factor (also known as AP1) is likely to be the downstream effector
of the pathway, acting on promoter regions of target genes to
activate their transcription. Other unknown signaling elements
may integrate the signaling pathway, such as different protein
kinases and transcription factors. Further experiments are
necessary to confirm the postulated interaction of each element
with upstream and downstream proteins.
An important point to be considered in S. mansoni TNF-a
signaling pathway is the presence of Caspases 3 and 8 and C-IAP
protein. Classically, caspases 3 and 8 are involved in the apoptosis
process induced by TNF-a signaling and are inhibited by c-IAP. No
direct evidence exists so far in the literature for the apoptosis process
in schistosomes. The present findings open a new perspective for S.
mansoni biology that warrants further investigation.
When cercariae penetrate the human skin, macrophages start
secreting TNF-a in that tissue [4]. We propose that the highest
expression level of SmTNFR observed in cercariae reflects an
evolutionary adaptation; during the penetration process, cercariae
will be exposed to host TNF-a in the skin and this could act to
promote parasite survival and development, in a similar manner as
described in adult worms by Davies et al [56].
Finally, this is the first work that evaluated the effect of a human
cytokine such as TNF-a on the expression profile of S. mansoni
using oligonucleotide arrays comprised of 44000 elements [37],
probing the entire set of known S. mansoni gene fragments.
We reasoned that the exposure of 3-hour old recently
transformed schistosomula to human TNF-a would somewhat
mimic the conditions at the skin during penetration. In fact, about
3-4 h after exposure to the host skin, schistosomula start invading
the epidermis where they will have contact with human TNF-a
[4]. In this respect, it is noteworthy that genes involved in mRNA
translation and protein synthesis were found among the enriched
GO categories in TNF-a treated schistosomula. High metabolic
rates are probably present, as the expression of pyruvate
dehydrogenase complex and the glucose transporter gene
(C800471.1) were increased (Table S4). Two proteins related to
cell cycle control were induced in early schistosomula treated with
human TNF-a: cell division cycle 23 (C800690.1) and cell-cycle
and apoptosis regulatory protein 1 (C917134.1) (Table S4). In
humans, TNF-a signaling resulting from TNFR2 activation is
described to induce cell proliferation through anti-apoptotic
mechanisms [54].
Table 5. Genes that comprise the most significantly enriched (p=10
229) network of differentially expressed genes with sustained
changes in their expression levels in adult worms treated with human TNF-alpha for 1 h and 24h.
Symbol Entrez Gene Name
FDR
(%)
Log
Ratio
Sub-cellular
location Family Probe Contig
PLBD2 phospholipase B domain containing 2, gi:229093316 0.00 0.37 Extracellular Space other Q2_P19393 C802110.1
SDHC succinate dehydrogenase complex, subunit C,
integral membrane protein, 15kDa, gi:4506863
0.00 20.25 Cytoplasm enzyme Q2_P06919 C812100.1
NT5C2 59-nucleotidase, cytosolic II, gi:6912598 0.55 0.28 Cytoplasm phosphatase Q2_P18085 C800231.1
VDAC1 voltage-dependent anion channel 1, gi:4507879 0.55 0.20 Cytoplasm ion channel Q2_P06247 C811048.1
ARPC1B actin related protein 2/3 complex, subunit 1B,
41kDa, gi:5031601
0.86 20.23 Cytoplasm other Q2_P07789 C813410.1
PDLIM1 PDZ and LIM domain 1, gi:13994151 0.86 0.25 Cytoplasm transcription
regulator
Q2_P25128 C809800.1
GPSN2 glycoprotein, synaptic 2, gi:24475816 1.16 20.26 Plasma Membrane other Q2_P06002 C810781.1
AP2S1 adaptor-related protein complex 2, sigma 1
subunit, gi:70906430
2.05 20.27 Cytoplasm transporter Q2_P05146 C809441.1
ATP1A3 ATPase, Na+/K+ transporting, alpha 3
polypeptide, gi:22748667
2.17 0.37 Plasma Membrane transporter Q2_P19925 C802766.1
SYNGR2 synaptogyrin 2, gi:4759202 2.17 20.30 Plasma Membrane other Q2_P26766 C812444.1
RPS23 ribosomal protein S23, gi:4506701 3.59 20.39 Cytoplasm translation
regulator
Q2_P02650 C805298.1
TMBIM1 transmembrane BAX inhibitor motif containing 1,
gi:50593008
4.03 20.26 Unknown other Q2_P18361 C800545.1
STARD3 StAR-related lipid transfer (START) domain
containing 3, gi:31543657
4.62 0.50 Cytoplasm transporter Q2_P23697 C807937.1
doi:10.1371/journal.pntd.0000556.t005
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early schistosomula by human TNF-a, such as Activin receptor
(C811502.1), Olfactory receptor (C903953.1), Retinoic acid
receptor RXR (Contig C910708.1), a putative seven-transmem-
brane receptor (C809780.1) and nicotinic acetylcholine receptor
(C812523.1) (Table S4). These TNF-a induced receptors may
increase parasite sensitivity to host stimuli.
A most interesting finding was the up-regulation of TRAF
expression (C905513.1) induced in early schistosomula by human
TNF-a (Table S4). Cercariae have the highest levels of SmTNFR
mRNA; cercariae-to-schistosomula early transformed parasites
exposed to TNF-a apparently signal a positive feed-back
regulation of expression of TRAF, a putative SmTNFR partner.
The target genes activated by human TNF-a in paired adult
worms have shown two distinct expression patterns: genes with
transient changes (that are induced in 1h and then repressed in
24hs or the opposite pattern) and genes with sustained changes in
their expression levels (induced or repressed by TNF-a, indepen-
dently of parasite’s exposure time). Among the genes induced in
1 h by TNF-a, we highlight those that are categorized in the
‘‘RNA binding’’ and ‘‘RNA processing’’ GO terms; they encode
proteins present in ribonucleoprotein complexes, such as Ribo-
somes (Table S8). AUT1 gene (C918331.1) had a significantly
induced expression in 1 h of treatment. AUT 1 is described in
Drosophila as essential for development and autophagy process [57]
(Table S7).
Among TNF-a target genes with transient expression it is worth
mentioning a set of genes related to egg laying (Table S7).
Curiously, Egg shell protein (C910370.1) and P40 egg shell protein
(C806383.1) had an induced expression at 1 h treatment and were
repressed at 24 h. On the contrary, p48 egg shell protein (contig
JAP04349.S) and Egg protein (C804676.1) along with gyneco-
phoral canal protein (C810707.1) had an opposite transient
expression change, being repressed at 1 h and induced at 24 h
treatment with TNF- a. Amiri et al [6] reported an increase in egg
laying induced by human TNF-a, whereas Haseeb et al [7]
described a decrease in egg production upon short time exposure
to TNF-a (1, 3 and 6 h). Our results revealed that there is a
complex pattern of regulation of the egg laying related genes upon
TNF-a treatment that deserves additional characterization.
Figure 7. Most significantly enriched (p=10
229) network of S. mansoni genes that were sustainably altered at 1h and 24h treatment
with human TNF-alpha. In red are the genes that were induced in 1 h and 24 h with respect to their control. In green are genes that were
repressed in 1 h and 24 h with respect to their control. Non-significantly altered genes are in grey; in white are the human genes known to belong to
the network for which no homolog was found in S. mansoni. MIR124 stands for human microRNA 124. Direct relations are marked by continuous
lines, while indirect relations have dashed lines.
doi:10.1371/journal.pntd.0000556.g007
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expression in adults (1 h and 24 h treatment) of MAPKKK5
(contig C902728, probe Q2_P09086), a kinase member of the
TNF-a signal transduction pathway (Table S10). MAPKKK5
kinase protein acts at the initial steps of the signaling process by
phosphorylation and activation of other target kinases; the increase
of MAPKKK5 expression suggests that as soon as 1 h after TNF-a
exposure the signaling pathway is activated not only by
phosphorylation but also by an increase in the number of
MAPKKK5 molecules present in the cell.
In conclusion, the present work reports an important signaling
element in schistosomes, namely SmTNFR, thus giving a
molecular perspective to the effects of human TNF-a on S.
mansoni. The possible receptor is described along with all the
elements of a conserved TNF-a signaling pathway together with a
set of probable target genes activated by TNF-a in the parasite.
The work extends the complexity of signal transduction biology of
S. mansoni.
Supporting Information
Figure S1 Most significantly enriched network (p=10
259)o fS.
mansoni genes that were transiently altered at 1h and 24h treatment
with TNF-alpha. In red are the genes that were repressed at 1 h
with respect to their control and induced at 24 h. In green are genes
that were induced at 1 h with respect to their control and repressed
at 24 h. Non-significantly altered genes are in grey; in white are the
human genes known to belong to the network, for which no
homolog was found in S. mansoni. Direct relations are marked by
continuous lines, while indirect relations have dashed lines.
Found at: doi:10.1371/journal.pntd.0000556.s001 (0.10 MB PDF)
File S1 Contig sequences in a FASTA format.
Found at: doi:10.1371/journal.pntd.0000556.s002 (17.60 MB
DOC)
Table S1 Part A, primers used in real time RT-PCR, cloning
experiments and RACE experiments; Part B, oligoarray probe
numbers, the corresponding ESTs contig represented by each
probe, the predicted protein Smp_xxxxxx number when available,
and the putative human homolog (E-value ,1e-20) accession
number when available.
Found at: doi:10.1371/journal.pntd.0000556.s003 (18.58 MB
XLS)
Table S2 S. mansoni orthologs to human TNF-alpha signaling
pathway elements.
Found at: doi:10.1371/journal.pntd.0000556.s004 (0.04 MB XLS)
Table S3 Expressed genes and differentially expressed genes in
schistosomula treated with human TNF-alpha for 1 h.
Found at: doi:10.1371/journal.pntd.0000556.s005 (0.02 MB XLS)
Table S4 List of 548 unique genes (755 probes) differentially
expressed between treated and control schistosomula at 1 h
treatment with human TNF-alpha.
Found at: doi:10.1371/journal.pntd.0000556.s006 (0.41 MB XLS)
Table S5 Significantly enriched (p-value,0.05) GO categories
among the genes with changes in expression level in schistosomula
treated for 1h with TNF-alpha.
Found at: doi:10.1371/journal.pntd.0000556.s007 (0.02 MB XLS)
Table S6 Expressed genes and genes with transient differential
expression in adult worms treated with human TNF-alpha for 1 h
or 24 h.
Found at: doi:10.1371/journal.pntd.0000556.s008 (0.02 MB XLS)
Table S7 List of 1365 unique genes (1594 probes) differentially
expressed between treated and control paired adult worms with
transient changes at 1 h or at 24 h of treatment with human TNF-
alpha.
Found at: doi:10.1371/journal.pntd.0000556.s009 (0.73 MB XLS)
Table S8 Significantly enriched GO categories (p-value ,0.05)
for genes with changes in expression in adult worms treated for 1 h
and/or 24 h with TNF-alpha.
Found at: doi:10.1371/journal.pntd.0000556.s010 (0.02 MB XLS)
Table S9 Expressed genes and genes with sustained differential
expression in adult worms treated with human TNF-alpha for 1 h
and 24 h.
Found at: doi:10.1371/journal.pntd.0000556.s011 (0.02 MB XLS)
Table S10 List of 492 genes (626 probes) with sustained
differential expression between treated and control paired
Figure 8. Schematic representation of modules for cysteine-
rich domains (CRD) and for death domains of selected TNF
receptors. Colored ellipses represent modules or domains detected in
the represented TNF receptors. This simplified diagram is intended only
to reflect modules organization as proposed in [11] and contains no
information relative to size of modules or size of the whole receptor.
Solid arrows above the scheme point to the receptors that have TNF-a
ligand interaction, and the dotted line arrow indicates a putative
interaction of SmTNFR with TNF-a ligand.
doi:10.1371/journal.pntd.0000556.g008
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alpha.
Found at: doi:10.1371/journal.pntd.0000556.s012 (0.32 MB XLS)
Table S11 List of 58 genes differentially expressed in common
between schistosomula and adult paired worms treated with TNF-
alpha.
Found at: doi:10.1371/journal.pntd.0000556.s013 (0.05 MB XLS)
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